Drug Shortage Report for SANDOZ LISINOPRIL HCT

Last updated on 2020-03-30 History
Report ID 93394
Drug Identification Number 02302365
Brand name SANDOZ LISINOPRIL HCT
Common or Proper name LISINO+HCT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE LISINOPRIL
Strength(s) 12.5MG 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2019-08-05
Estimated end date 2020-02-24
Actual end date 2020-02-27
Shortage status Resolved
Updated date 2020-03-30
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-03-30 French Compare
v5 2020-03-30 English Compare
v4 2019-09-25 French Compare
v3 2019-09-25 English Compare
v2 2019-09-10 French Compare
v1 2019-09-10 English Compare

Showing 1 to 6 of 6